http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022056392-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_859d7efc6733b4930e72003b3d96b82a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 2021-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc56f7638338a67db228825d8dbe456f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0f9bc43bdc4a88152144290911af30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc1bbb60fede32cd356db0450112118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4172efc19da3ea84461535399226eef3
publicationDate 2022-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022056392-A1
titleOfInvention Bioerodible ocular drug delivery insert and therapeutic method
abstract This invention relates to implantable bioerodible inserts for delivering an active pharmaceutical ingredient to the eye. The invention also relates to methods of treatment using such inserts as well as methods of manufacturing such inserts.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023173093-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023173088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023173095-A1
priorityDate 2020-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004066980-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015133878-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019046434-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019202603-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468017025

Total number of triples: 35.